N01269 106 — Philadelphia, Pennsylvania

N01269 106 is a clinical research site located in Philadelphia, Pennsylvania, United States 19134.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

N01269 106 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Childhood Absence Epilepsy, Juvenile Absence Epilepsy.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01269 106?

N01269 106 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01269 106 conducted?

N01269 106 has 1 clinical trials on record, with 1 currently active. Their work covers Childhood Absence Epilepsy, Juvenile Absence Epilepsy.

Is N01269 106 accredited by Crixeo Health?

N01269 106 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01269 106?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.